Home | Volume 9

In vivo delivery technique of nucleic acid compounds using atelocollagen: Its use in cancer therapeutics targeted at the heparin-binding growth factor midkine

Dr. Yoshifumi Takei et. al.

Download as PDF : 26._Takei_&_Kadomatsu,_257-.pdf : 217848 bytes


Previous Article: Evolutionary dynamics of drug resistance in cancer
Next Article: Rho/Rho-kinase as potential therapeutic targets for CNS injury
The Publication:
In vivo delivery technique of nucleic acid compounds using atelocollagen: Its use in cancer therapeutics targeted at the heparin-binding growth factor midkine
is not formatted in HTML just yet, but will be available very soon!
Please view as a PDF: 26._Takei_&_Kadomatsu,_257-.pdf in the meantime.